ARCTURUS THERAPEUTICS INC.

Products

Category Product Brand Description
mRNA: Therapeutics and Global Markets (BIO212C)
KOSTAIVE
Indication: COVID-19 , Stage:Approved JP, Approved EU
LUNAR (ARCT-2138)
Seasonal Influenza:Phase 1
Undisclosed
Infectious Disease:Preclinical

This information is available for BCC Research members only.

AI Sentiment